Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Rockwell gains on Phase III anemia data for SFP

Rockwell Medical Technologies Inc. (NASDAQ:RMTI) said 11 ug/dL Soluble Ferric Pyrophosphate (SFP) delivered via hemodialysate

Read the full 159 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE